CASP4 and chronic obstructive pulmonary disease: The activation of the AIM2 inflammasome triggered the release of pro-inflammatory cytokines, such as interleukin (IL)-1α and tumor growth factor (TGF)-β in exacerbated PBMCs from COPD patients in a caspase-4 noncanonical inflammasome-dependent manner [39].